Vicarious Surgical Inc (NYSE:RBOT – Get Rating) shares were down 4.6% during trading on Monday . The stock traded as low as $2.66 and last traded at $2.68. Approximately 144,413 shares were traded during mid-day trading, a decline of 61% from the average daily volume of 372,564 shares. The stock had previously closed at $2.81.
Vicarious Surgical Price Performance
The firm has a market cap of $327.95 million, a price-to-earnings ratio of 3.77 and a beta of 1.09. The business has a fifty day simple moving average of $2.56 and a 200 day simple moving average of $3.35.
Get
Vicarious Surgical alerts:
Vicarious Surgical (NYSE:RBOT – Get Rating) last released its quarterly earnings results on Monday, November 7th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.03). During the same period in the previous year, the firm earned ($0.09) earnings per share. On average, research analysts anticipate that Vicarious Surgical Inc will post -0.66 earnings per share for the current fiscal year.
Insider Buying and Selling at Vicarious Surgical
In other news, Director Philip Liang sold 15,000 shares of the stock in a transaction that occurred on Thursday, November 10th. The shares were sold at an average price of $3.59, for a total value of $53,850.00. Following the completion of the transaction, the director now directly owns 1,185,320 shares in the company, valued at $4,255,298.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at
this hyperlink. In other Vicarious Surgical news, Director Philip Liang sold 15,000 shares of Vicarious Surgical stock in a transaction on Thursday, November 10th. The shares were sold at an average price of $3.59, for a total transaction of $53,850.00. Following the completion of the sale, the director now owns 1,185,320 shares of the company's stock, valued at approximately $4,255,298.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at
this link. Also, CTO Sammy Khalifa sold 18,041 shares of Vicarious Surgical stock in a transaction on Monday, November 21st. The shares were sold at an average price of $3.29, for a total transaction of $59,354.89. Following the sale, the chief technology officer now directly owns 994,493 shares of the company's stock, valued at approximately $3,271,881.97. The disclosure for this sale can be found
here. Insiders sold a total of 117,873 shares of company stock valued at $376,819 in the last ninety days. Insiders own 52.48% of the company's stock.
Institutional Trading of Vicarious Surgical
A number of institutional investors and hedge funds have recently added to or reduced their stakes in RBOT. International Assets Investment Management LLC acquired a new position in Vicarious Surgical during the fourth quarter worth $27,000. Strs Ohio increased its holdings in Vicarious Surgical by 395.3% in the 4th quarter. Strs Ohio now owns 62,900 shares of the company's stock valued at $127,000 after buying an additional 50,200 shares during the period. Rothschild Investment Corp IL increased its holdings in Vicarious Surgical by 28.5% in the 4th quarter. Rothschild Investment Corp IL now owns 168,831 shares of the company's stock valued at $341,000 after buying an additional 37,417 shares during the period. Twelve Points Wealth Management LLC increased its holdings in Vicarious Surgical by 86.0% in the 4th quarter. Twelve Points Wealth Management LLC now owns 100,473 shares of the company's stock valued at $203,000 after buying an additional 46,462 shares during the period. Finally, Riverwater Partners LLC grew its holdings in shares of Vicarious Surgical by 63.0% during the 4th quarter. Riverwater Partners LLC now owns 27,853 shares of the company's stock valued at $56,000 after purchasing an additional 10,762 shares during the last quarter. Institutional investors own 42.77% of the company's stock.
Vicarious Surgical Company Profile
(Get Rating)
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
See Also
- Get a free copy of the StockNews.com research report on Vicarious Surgical (RBOT)
- Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
- SoFi Technologies Smashes Earnings but Beware the Fed Decision
- Buying The Dip In Colgate-Palmolive
- Mullen Automotive On Hiring Spree, What Could That Mean?
- InterDigital Raises Its Earnings Guidance
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
